EW: edwards.com Company Cash on Hand

Edwards Lifesciences (EW) - corporate logo

The current cash balance of Edwards Lifesciences (EW), where this figure equals 4.69, correlates with the implementation of minimally invasive valves and regulatory support. Export barriers and logistical complexities in Asia limit the global sales reach of Edwards Lifesciences (EW). Business stability is bolstered by the loyalty of elite cardiac engineers, who are retained through generous bonuses. This chart's dynamics help assess the company's solvency and profitability risks.

EW - Edwards Lifesciences Corp Company Cash Reserve over the range 07/04/2022 - 11/21/2026

Analytical breakdowns for Edwards Lifesciences

- stock value and consensus price forecast:
Basic company analysis:EW Edwards Lifesciences Corp
Product sample of edwards.com

This metric measures the business's net liquidity, excluding accounts receivable to assess the company's actual ability to meet obligations instantaneously. Investors utilize this metric to analyze the balance between financial stability and capital efficiency. By examining the cash reserves chart, one can evaluate the funding pace for Edwards Lifesciences plant modernizations and the implementation of robotic control systems. Sufficient funding ensures the seamless expansion of production lines without excessive credit pressure.

Competitor analysis for Edwards Lifesciences

Company Cash Volume BSX|Company Cash Volume resmed.com (RMD)|Company Cash Volume PODD (insulet.com)|Zimmer Biomet Holdings Inc - Company Cash Funds|COO: Company Cash on Hand|ALGN: Company Cash Funds|GMED (Globus Medical, Inc.) - Company Cash on Hand|TransMedics Organ Care System - Company Cash Balance|ATEC (Alphatec Corp) - Company Cash Volume|Company Cash Reserve CryoLife AORT|Company Cash Funds Enovis Corp (ENOV)|Integra LifeSciences (IART) - Company Cash Position|Establishment Labs Inc - Company Cash on Hand|Company Cash Volume Beta Bionics Inc BBNX|IRADIMED Corp - Company Cash Volume|Company Liquid Assets Embecta Corp EMBC|Tandem Diabetes Care, Inc. (TNDM) - Company Cash Funds|Company Total Cash Volume AXGN (Axogen Surgical)|Company Cash Funds si-bone.com|Company Cash on Hand Orthofix Medical Inc. (OFIX)|Company Cash Funds Bioventus Corp (BVS)|KIDS - Company Cash Reserve|Company Cash Funds Treace Medical Concepts TMCI|SRTA: Company Cash and Cash Equivalents|CARL: Company Cash on Hand|rxsight.com - Company Total Cash Amount|CLPT: Company Cash Volume|STXS - Company Liquid Assets|STIM (neurostar.com) - Company Cash Volume|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)